Related Experiment Video
Updated: Jun 11, 2026

11:04
Control of Cell Geometry through Infrared Laser Assisted Micropatterning
Published on: July 10, 2021
3.4K
Minimal-Invasive 3D Laser Printing of Microimplants in Organismo
Cassian Afting1,2,3, Philipp Mainik4,5, Clara Vazquez-Martel4,5
1Centre for Organismal Studies Heidelberg (COS), Heidelberg University, 69120, Heidelberg, Germany.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|June 12, 2024
Summary
A new 3D laser printing platform enables in situ manufacturing of biocompatible microimplants directly within organisms. This technology opens new avenues for in vivo tissue engineering and studying biological responses to custom-designed implants.
Area of Science:
- Biomedical Engineering
- Tissue Engineering
- Regenerative Medicine
Background:
- Multi-photon 3D laser printing is used for in vitro biocompatible scaffolds.
- In vivo tissue engineering is limited to pre-printed scaffolds or bioinks.
- A platform for in vivo/in situ 3D printing of synthetic polymer microimplants is lacking.
Purpose of the Study:
- To present a novel platform for minimal-invasive, in situ 3D laser printing of microimplants.
- To demonstrate the feasibility of manufacturing synthetic polymer-based microimplants directly within living organisms.
- To provide a framework for investigating biological responses to in situ printed constructs.
Main Methods:
- Development of a 3D laser printing platform utilizing one-photon and multi-photon photopolymerization.
- Employment of a commercially available elastomeric ink for biocompatible microimplant fabrication.
- In vivo application and biological response assessment in model organisms (Oryzias latipes and Drosophila melanogaster embryos).
Main Results:
- Successful in situ 3D printing of biocompatible synthetic polymer microimplants within model organisms.
- Demonstration of biological responses to the in situ printed microimplants.
- Establishment of a versatile platform for in vivo microimplant manufacturing.
Conclusions:
- The presented platform enables direct, in vivo 3D manufacturing of microimplants using synthetic polymer-based inks.
- This technology facilitates the study of biological interactions with precisely engineered in situ constructs.
- The platform holds significant potential for advancing tissue engineering and regenerative medicine in vivo.

